Sterling Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-345,406	Closed	-$1.01M	–	930
2018 Q1	$1.01M	Hold	345,406	–	–	0.01%	609
2017 Q4	$946K	Hold	345,406	–	–	0.01%	648
2017 Q3	$1.17M	Hold	345,406	–	–	0.01%	559
2017 Q2	$853K	Buy	+345,406	New	+$794K	0.01%	663
2017 Q1	–	Sell	-204,916	Closed	-$434K	–	1060
2016 Q4	$434K	Hold	204,916	–	–	﹤0.01%	794
2016 Q3	$686K	Buy	+204,916	New	+$650K	0.01%	647
2015 Q3	–	Sell	-64,414	Closed	-$414K	–	1103
2015 Q2	$414K	Sell	64,414 -977	-1%	-$6.54K	﹤0.01%	751
2015 Q1	$460K	Sell	65,391 -143,510	-69%	-$1.04M	﹤0.01%	717
2014 Q4	$1.61M	Sell	208,901 -2,451	-1%	-$19.4K	0.01%	490
2014 Q3	$1.58M	Buy	+211,352	New	+$1.96M	0.02%	462
2014 Q2	–	Sell	-159,473	Closed	-$1.32M	–	1004
2014 Q1	$1.32M	Buy	159,473 +122,675	+333%	+$1.05M	0.01%	490
2013 Q4	$311K	Buy	+36,798	New	+$310K	﹤0.01%	717
2013 Q3	–	Sell	-40,986	Closed	-$316K	–	756
2013 Q2	$316K	Buy	+40,986	New	+$320K	﹤0.01%	474